ArticleBehavioral and brain functions : BBF2024

Investigation in the cannabigerol derivative VCE-003.2 as a disease-modifying agent in a mouse model of experimental synucleinopathy.

Sonia Burgaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.